Cargando…

Construction of refined staging classification systems integrating FIGO/T‐categories and corpus uterine invasion for non‐metastatic cervical cancer

BACKGROUND: To investigate the prognostic value of corpus uterine invasion (CUI) in cervical cancer (CC), and determine the necessity to incorporate it for staging. METHODS: A total of 809 cases of biopsy‐proven, non‐metastatic CC were identified from an academic cancer center. Recursive partitionin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiao‐Dan, Chen, Kai, Shi, Liu, Luo, Ying‐Shan, Ou‐Yang, Yi, Li, Jun‐Yun, Huo, Lan‐Qing, Huang, Lin, Chen, Fo‐Ping, Cao, Xin‐Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417195/ https://www.ncbi.nlm.nih.gov/pubmed/37326385 http://dx.doi.org/10.1002/cam4.6179

Ejemplares similares

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

The FIGO Ovulatory Disorders Classification System
por: Munro, Malcolm G, et al.
Publicado: (2022)

The FIGO ovulatory disorders classification system
por: Munro, Malcolm G., et al.
Publicado: (2022)

Cervical cancer invading the uterine corpus and sigmoid colon: A case report
por: Huang, Shimin, et al.
Publicado: (2022)

A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system
por: Kim, Ha-Jeong, et al.
Publicado: (2013)

Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer
por: Wagner-Larsen, Kari S., et al.
Publicado: (2022)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

Mesothelial cyst of uterine corpus misdiagnosed as leiomyoma
por: Mo, Shi-Ping, et al.
Publicado: (2019)

Abnormal uterine bleeding types according to the PALM-COEIN FIGO classification in a medically underserved American community
por: Sabre, Alexander, et al.
Publicado: (2021)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer
por: Kuji, Shiho, et al.
Publicado: (2014)

Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
por: Chen, Xiaolin, et al.
Publicado: (2022)

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix
por: Kasamatsu, T, et al.
Publicado: (2009)

Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases
por: Chen, Fo-Ping, et al.
Publicado: (2021)

Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2019)

Clinical Analysis and Prognostic Prediction Model for Patients with Uterine Leiomyosarcoma at FIGO Stage I
por: Chen, Shuya, et al.
Publicado: (2023)

Implications of the revised cervical cancer FIGO staging system
por: Bhatla, Neerja, et al.
Publicado: (2021)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer
por: Huang, Xiao-Dan, et al.
Publicado: (2023)

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study
por: Ye, Yanna, et al.
Publicado: (2023)

Erratum: Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2021)

Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage
por: Balaya, Vincent, et al.
Publicado: (2020)

Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
por: Li, Zhiqiang, et al.
Publicado: (2022)

Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study
por: Duan, Hui, et al.
Publicado: (2023)

Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II
por: Grote, Hans Jürgen, et al.
Publicado: (2001)

Construction of the novel immune risk scoring system related to CD8(+) T cells in uterine corpus endometrial carcinoma
por: Zhang, Ganghua, et al.
Publicado: (2023)

Evaluation of predictions in the CASP10 model refinement category
por: Nugent, Timothy, et al.
Publicado: (2014)

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

FIGO good practice recommendations on cervical cerclage for prevention of preterm birth
por: Shennan, Andrew, et al.
Publicado: (2021)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model
por: Cui, Yun-Qian, et al.
Publicado: (2021)

Papillary thyroid carcinoma with massive metastasis in the uterine corpus: a case report
por: Wang, Jian-hong, et al.
Publicado: (2013)

Case report: Malignant teratoma of the uterine corpus
por: Newsom-Davis, Thomas, et al.
Publicado: (2009)

FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
por: Prat, Jaime
Publicado: (2015)

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
por: Kasius, Jenneke C., et al.
Publicado: (2021)

Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study
por: Ariga, Takuro, et al.
Publicado: (2015)

The bidirectional association among female hormone‐related cancers: breast, ovary, and uterine corpus
por: Chen, Min‐Chi, et al.
Publicado: (2018)

Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer
por: Kuroda, Yuuki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h01e07m6q3jlv5vkjd3lh5v9cn